Please login to the form below

Not currently logged in
Email:
Password:

Former Roche CEO and chairman joins Arix Bioscience

Dr Franz Humer becomes a senior independent director

Arix Bioscience Dr Franz HumerHealthcare and life science company Arix Bioscience has appointed Dr Franz Humer as a senior independent director.

Most recently, Dr Humer served as chairman and chief executive at Roche, having joined the company as head of pharmaceuticals in 1995 before becoming chief operating officer in 1996.

He is currently chairman of Diageo, a consumer goods company, and a non-executive director of Chugai Pharmaceuticals, Citigroup and Kite Pharma.

Jonathan Peacock, chairman of Arix Bioscience, said: “We are delighted to welcome to the board a director of Franz's stature.

“His experience and judgement will be a tremendous asset to Arix Bioscience as we continue to support emerging and innovative companies globally.

“Franz further strengthens a very experience board of executive and non-executive directors.”

10th November 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...
BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....

Infographics